Skip to main content
SpringerLink
Log in

A cost-effective alternative for nonsmall cell lung cancer

  • Newsletter Article
  • Published:
PharmacoResources

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

A cost-effective alternative for nonsmall cell lung cancer. Pharmacoecon. Outcomes News 7, 9 (1994). https://doi.org/10.1007/BF03293587

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03293587

Keywords

Search

Navigation